Financial Statements
Ceylon Hospitals PLC
For the 2nd Quarter ended 30th September 2022
Financial Statements for the Six Months ended 30th September 2022 | ||||||||
Consolidated Statement of Profit or Loss and Other Comprehensive Income | Accumulated Period of 6 Months | |||||||
Group | Company | Group | Company | |||||
03 Months | 03 Months | 03 Months | 03 Months | 6 Months | 6 Months | 6 Months | 6 Months | |
Ended | Ended | Ended | Ended | Ended | Ended | Ended | Ended | |
30/09/2022 | 30/09/2021 | 30/09/2022 | 30/09/2021 | 30/09/2022 | 30/09/2021 | 30/09/2022 | 30/09/2021 | |
Rs. '000 | Rs. '000 | Rs. '000 | Rs. '000 | Rs. '000 | Rs. '000 | Rs. '000 | Rs. '000 | |
Revenue | 1,935,334 | 2,100,407 | 1,090,224 | 1,430,105 | 3,579,817 | 3,980,538 | 1,996,441 | 2,689,770 |
Cost of Sales | (785,656) | (743,319) | (480,497) | (554,387) | (1,406,332) | (1,477,865) | (823,087) | (1,071,081) |
Gross Profit | 1,149,678 | 1,357,088 | 609,727 | 875,718 | 2,173,485 | 2,502,673 | 1,173,354 | 1,618,690 |
Other Operating Income | 48,833 | 15,866 | 15,183 | 11,617 | 35,665 | 24,481 | 23,989 | 16,309 |
Administrative Expenses | (666,812) | (810,571) | (425,869) | (602,898) | (1,288,240) | (1,510,204) | (823,762) | (1,104,374) |
Other Operating Expenses | (203,973) | (172,074) | (91,400) | (116,087) | (400,623) | (334,394) | (211,896) | (226,031) |
Results from Operating Activities | 327,726 | 390,309 | 107,641 | 168,351 | 520,287 | 682,556 | 161,685 | 304,594 |
Finance Cost | (14,743) | (16,596) | (11,876) | (16,480) | (30,326) | (40,468) | (24,554) | (39,247) |
Finance Income | 65,125 | 15,344 | 28,270 | 94,187 | 130,465 | 34,986 | 241,425 | 246,694 |
Gain on Bargain Purchase | - | - | - | - | - | 12,002 | - | - |
Share of Profit of an Equity Accounted Investee | - | - | - | - | - | 13,263 | - | - |
Profit before Taxation | 378,108 | 389,056 | 124,035 | 246,058 | 620,426 | 702,338 | 378,556 | 512,041 |
- | ||||||||
Taxation | (88,329) | (95,014) | (11,731) | (46,889) | (123,643) | (178,556) | (26,876) | (88,655) |
Net Profit after Taxation | 289,779 | 294,042 | 112,304 | 199,169 | 496,783 | 523,782 | 351,680 | 423,386 |
Other Comprehensive Income | ||||||||
Items will not be reclassified to profit or loss | ||||||||
Net Change in Fair Value on Equity Investments at | ||||||||
FVOCI | 3,922 | 8 | (1,632) | 8 | 2,042 | 64 | 28 | 64 |
Other Comprehensive Income for the Year | 3,922 | 8 | (1,632) | 8 | 2,042 | 64 | 28 | 64 |
Total Comprehensive Income for the Year | 293,701 | 294,050 | 110,672 | 199,177 | 498,825 | 523,846 | 351,708 | 423,450 |
Profit Attributable to: | ||||||||
Equity Holders of the Parent | 251,147 | 244,288 | 112,304 | 199,169 | 435,446 | 437,979 | 351,680 | 423,386 |
Non-Controlling Interest | 38,632 | 49,755 | - | - | 61,337 | 85,803 | - | - |
289,779 | 294,042 | 112,304 | 199,169 | 496,783 | 523,782 | 351,680 | 423,386 |
Total Comprehensive Income Attributable to: Equity Holders of the Parent Non-Controlling Interest
Earnings per Share - Basic
254,023 | 244,296 | 110,672 | 199,177 | 437,109 | 438,043 | 351,708 | 423,450 |
39,678 | 49,755 | - | - | 61,716 | 85,803 | - | - |
293,701 | 294,050 | 110,672 | 199,177 | 498,825 | 523,846 | 351,708 | 423,450 |
7.41 | 7.21 | 3.32 | 5.88 | 12.86 | 12.93 | 10.38 | 12.50 |
The above figures are provisional and subject to audit.
Ceylon Hospitals PLC | -1- |
Financial Statements for the Six Months ended 30th September 2022
Consolidated Statement of Financial Position | ||||||
GROUP | COMPANY | GROUP | COMPANY | |||
Audited | Audited | Unaudited | Unaudited | Unaudited | Unaudited | |
As at | As at | As at | As at | As at | As at | |
31/03/2022 | 31/03/2022 | 30/09/2022 | 30/09/2021 | 30/09/2022 | 30/09/2021 | |
Rs. '000 | Rs. '000 | Rs. '000 | Rs. '000 | Rs. '000 | Rs. '000 | |
ASSETS | ||||||
Non-Current Assets | ||||||
8,481,203 | 5,592,128 | Property, Plant and Equipment | 9,186,655 | 7,941,871 | 6,169,527 | 5,287,830 |
288,954 | 288,954 | Right of Use Assets | 286,690 | 204,321 | 284,060 | 204,321 |
- | 1,457,821 | Investments in Subsidiary | - | - | 1,457,821 | 1,457,821 |
272,923 | 71,416 | Other Financial Assets | 298,841 | 332,728 | 74,114 | 67,532 |
890 | - | Prepaid Rent | - | 716 | - | - |
9,043,970 | 7,410,319 | 9,772,186 | 8,479,636 | 7,985,522 | 7,017,504 | |
Current Assets | ||||||
835,149 | 693,571 | Inventories | 951,788 | 593,760 | 750,526 | 503,038 |
306,454 | 214,955 | Trade and Other Receivables | 335,117 | 429,157 | 201,081 | 243,957 |
252,441 | 195,053 | Prepayments | 671,170 | 203,421 | 459,130 | 153,405 |
1,934 | 75,921 | Amount Due from Related Parties | 4,765 | 1,942 | 70,922 | 79,682 |
1,451,388 | 659,287 | Other Financial Assets | 1,018,082 | 939,384 | 397,222 | 131,638 |
13,278 | 13,259 | Tax Refund Due | 13,259 | - | 13,259 | - |
898,189 | 129,295 | Cash and Cash Equivalents | 501,920 | 693,099 | 195,754 | 124,132 |
3,758,833 | 1,981,341 | 3,496,101 | 2,860,763 | 2,087,894 | 1,235,852 | |
12,802,803 | 9,391,660 | Total Assets | 13,268,287 | 11,340,399 | 10,073,416 | 8,253,356 |
EQUITY AND LIABILITIES | ||||||
Equity Attributable to Equity holders of the parent | ||||||
916,366 | 916,366 | Stated Capital | 916,366 | 916,366 | 916,366 | 916,366 |
2,691,662 | 2,134,544 | Revaluation Reserve | 2,691,662 | 2,691,662 | 2,134,544 | 2,134,544 |
65,868 | 600 | Fair Value Reserve | 67,531 | 68,500 | 628 | 192 |
3,873,950 | 2,695,436 | Revenue Reserves | 4,140,032 | 3,281,025 | 2,877,751 | 2,301,393 |
7,547,846 | 5,746,946 | 7,815,591 | 6,957,553 | 5,929,289 | 5,352,495 | |
734,254 | - | Non-Controlling Interests | 759,599 | 691,378 | - | - |
8,282,100 | 5,746,946 | Total Equity | 8,575,190 | 7,648,931 | 5,929,289 | 5,352,495 |
Non-Current Liabilities | ||||||
1,701,501 | 1,606,247 | Interest Bearing Loans and Borrowings | 1,882,377 | 881,800 | 1,808,464 | 831,341 |
- | 31,470 | Deferred Revenue | - | - | 28,785 | 32,589 |
177,998 | 156,790 | Retirement Benefit Obligations | 182,741 | 247,654 | 159,371 | 221,519 |
707,793 | 452,599 | Deferred Tax Liabilities | 717,402 | 649,962 | 452,599 | 440,809 |
2,587,292 | 2,247,106 | 2,782,520 | 1,779,416 | 2,449,219 | 1,526,258 | |
Current Liabilities | ||||||
246,765 | 94,527 | Bank Overdraft | 188,526 | 233,260 | 154,964 | 126,197 |
306,060 | 248,830 | Interest Bearing Loans and Borrowings | 316,774 | 368,070 | 268,043 | 328,959 |
1,247,893 | 862,449 | Trade and Other Payables | 1,296,202 | 1,190,551 | 770,656 | 806,833 |
127,894 | 73,281 | Taxation Payable | 87,723 | 118,397 | 13,121 | 54,393 |
4,799 | 118,521 | Amount Due to Related Parties | 21,352 | 1,774 | 488,124 | 58,221 |
1,933,411 | 1,397,608 | 1,910,577 | 1,912,052 | 1,694,908 | 1,374,603 | |
12,802,803 | 9,391,660 | Total Equity and Liabilities | 13,268,287 | 11,340,399 | 10,073,416 | 8,253,356 |
The above figures are provisional and subject to audit.
Sgd
Thusitha Rubasinghe
Chief Financial Officer
The Board of Directors is responsible for the preparation and presentation of these Financial Statements.
Signed for and on behalf of the Board by,
Sgd | Sgd |
A E Tudawe | U D Tudawe |
Chairman | Director |
10th November 2022 | |
Ceylon Hospitals PLC | - 2 - |
Financial Statements for the Six Months ended 30th September 2022
CEYLON HOSPITALS PLC
STATEMENT OF CHANGES IN EQUITY
Group | |||||||
Stated | Revaluation | Fair Value | Revenue | Total | Non-Controlling | Total | |
Capital | Reserve | Reserve | Reserves | Interests | |||
Rs. '000 | Rs. '000 | Rs. '000 | Rs. '000 | Rs. '000 | Rs. '000 | Rs. '000 | |
Balance as at 31st March 2021 | 916,366 | 2,691,662 | 68,436 | 2,951,439 | 6,627,903 | 592,626 | 7,220,529 |
Net Profit for the Year | - | - | - | 982,324 | 982,324 | 127,202 | 1,109,526 |
Other Comprehensive Income | |||||||
Actuarial Gain on Gratuity Valuation | - | - | - | 55,965 | 55,965 | 300 | 56,265 |
Deferred Tax on Gratuity Valuation | - | - | - | (6,342) | (6,342) | 332 | (6,010) |
Prior Year Adjustments - Inventory Written-off | - | - | - | (989) | (989) | (230) | (1,219) |
Net Change in Fair Value on Equity Investments at FVTOCI | - | - | (2,568) | - | (2,568) | 217 | (2,351) |
Share Buyback | - | - | - | (54) | (54) | - | (54) |
Total Comprehensive Income for the Year | - | - | (2,568) | 1,030,904 | 1,028,335 | 127,822 | 1,156,158 |
Transactions with Owners in their capacity as Owners | |||||||
Non-Controlling Interest on Acquisition of Subsidiary | - | - | - | - | - | 127,301 | 127,301 |
Dividend Paid - Ordinary Shares | - | - | - | (108,393) | (108,393) | (113,495) | (221,888) |
- | - | - | (108,393) | (108,393) | 13,806 | (94,587) | |
Balance as at 31st March 2022 | 916,366 | 2,691,662 | 65,868 | 3,873,950 | 7,547,845 | 734,254 | 8,282,100 |
Net Profit for the Six months ended 30 September 2022 | - | - | - | 435,446 | 435,446 | 61,337 | 496,783 |
Other Comprehensive Income | |||||||
Net Profit on equity instruments designnated at fair- | |||||||
-Value through other comprehensive income | - | - | 1,663 | - | 1,663 | 379 | 2,042 |
Total Comprehensive Income for the Six Months Ended 30 September 2022 | - | - | 1,663 | 435,446 | 437,109 | 61,716 | 498,825 |
Transactions with Owners in their capacity as Owners | |||||||
Shares issued at Rights Issue by subsidiary | - | - | - | - | - | 5,860 | 5,860 |
Dividend Paid - Ordinary Shares | - | - | - | (169,364) | (169,364) | (42,231) | (211,595) |
- | - | - | (169,364) | (169,364) | (36,371) | (205,735) | |
Balance as at 30th September 2022 | 916,366 | 2,691,662 | 67,531 | 4,140,032 | 7,815,590 | 759,599 | 8,575,190 |
Company | |||||||
Stated | Revaluation | Fair Value | Revenue | Total | |||
Capital | Reserve | Reserve | Reserves | ||||
Rs. '000 | Rs. '000 | Rs. '000 | Rs. '000 | Rs. '000 | |||
Balance as at 31st March 2021 | 916,366 | 2,134,544 | 128 | 1,986,400 | 5,037,438 | ||
Net Profit for the Year | - | - | - | 770,550 | 770,550 | ||
Other Comprehensive Income | |||||||
Deferred Tax Effect on Revaluation Gain | - | - | - | - | - | ||
Actuarial Gain on Gratuity Valuation | - | - | - | 54,510 | 54,510 | ||
Deferred Tax Effect on Gratuity Valuation | - | - | - | (7,631) | (7,631) | ||
Net Change in Fair Value on Equity Investments at FVTOCI | - | - | 472 | - | 472 | ||
Total Comprehensive Income for the Year | - | - | 472 | 817,429 | 817,901 | ||
Transactions with Owners in their capacity as Owners | |||||||
Dividend Paid - Ordinary Shares | - | - | - | (108,393) | (108,393) | ||
- | - | - | (108,393) | (108,393) | |||
Balance as at 31st March 2022 | 916,366 | 2,134,544 | 600 | 2,695,436 | 5,746,946 | ||
Net Profit for the Six months ended 30 September 2022 | - | - | - | 351,680 | 351,680 | ||
Other Comprehensive Income | |||||||
Net Profit on equity instruments designnated at fair- | - | ||||||
-Value through other comprehensive income | - | - | 28 | - | 28 | ||
Total Comprehensive Income for the Six Months ended 30 September 2022 | - | - | 28 | 351,680 | 351,708 | ||
Transactions with Owners in their capacity as Owners | |||||||
Dividend Paid - Ordinary Shares | - | - | - | (169,364) | (169,364) | ||
- | - | - | (169,364) | (169,364) | |||
Balance as at 30th September 2022 | 916,366 | 2,134,544 | 628 | 2,877,751 | 5,929,289 |
- 3-
Financial Statements for the Six Months ended 30th September 2022
Consolidated Statement of Changes in Equity
For the period ended 30th September 2021
Group | |||||||
Stated | Revaluation | Fair Value | Revenue | Total | Non Controlling | Total | |
Capital | Reserve | Reserve | Reserves | Interests | |||
Rs. '000 | Rs. '000 | Rs. '000 | Rs. '000 | Rs. '000 | Rs. '000 | Rs. '000 | |
Balance as at 31st March 2020 | 916,366 | 2,483,785 | 65,922 | 2,439,753 | 5,905,826 | 587,760 | 6,493,586 |
Net Profit for the Year | - | - | - | 560,349 | 560,349 | 39,910 | 600,259 |
Other Comprehensive Income | |||||||
Deferred Tax Effect on Revaluation Gain | - | 207,877 | - | - | 207,877 | 752 | 208,629 |
Actuarial Gain on Gratuity valuation | - | - | - | 32,865 | 32,865 | 370 | 33,235 |
Deferred Tax Effect on Gratuity valuation | - | - | - | (7,007) | (7,007) | (610) | (7,617) |
Net Change in Fair Value on Equity Investments at FVTOCI | - | - | 2,514 | - | 2,514 | 554 | 3,068 |
Total Comprehensive Income for the Year | - | 207,877 | 2,514 | 586,206 | 796,597 | 40,975 | 837,572 |
Transactions with Owners in their capacity as Owners | |||||||
Share of additional capital attributable to NCI | - | - | - | - | - | 1,750 | 1,750 |
Dividend Paid - Ordinary Shares | - | - | - | (74,520) | (74,520) | (37,859) | (112,379) |
- | - | - | (74,520) | (74,520) | (36,109) | (110,629) | |
Balance as at 31st March 2021 | 916,366 | 2,691,662 | 68,436 | 2,951,439 | 6,627,903 | 592,626 | 7,220,530 |
Net Profit for the six months ended 30 September 2021 | - | - | - | 437,979 | 437,979 | 85,803 | 523,782 |
Other Comprehensive Income | |||||||
Net Change in Fair Value on Equity Investments at FVTOCI | - | - | 64 | - | 64 | - | 64 |
Total Comprehensive Income for the Six months ended 30 September 2021 | - | - | 64 | 437,979 | 438,043 | 85,803 | 523,846 |
Transactions with Owners in their capacity as Owners | |||||||
Non-Controlling Interest on Acquisition of Subsidiay | - | - | - | - | - | 126,444 | 126,444 |
Dividend Paid - Ordinary Shares | - | - | - | (108,393) | (108,393) | (113,496) | (221,889) |
- | - | - | (108,393) | (108,393) | 12,948 | (95,444) | |
Balance as at 30th September 2021 | 916,366 | 2,691,662 | 68,500 | 3,281,025 | 6,957,553 | 691,378 | 7,648,931 |
Company | |||||||
Stated | Revaluation | Fair Value | Revenue | Total | |||
Capital | Reserve | Reserve | Reserves | ||||
Rs. '000 | Rs. '000 | Rs. '000 | Rs. '000 | Rs. '000 | |||
Balance as at 31st March 2020 | 916,366 | 1,931,063 | - | 1,588,064 | 4,435,493 | ||
Net Profit for the Year | - | - | - | 446,118 | 446,118 | ||
Other Comprehensive Income | |||||||
Deferred Tax Effect on Revaluation Gain | - | 203,481 | - | - | 203,481 | ||
Actuarial Gain on Gratuity valuation | - | - | - | 31,090 | 31,090 | ||
Deferred Tax Effect on Gratuity valuation | - | - | - | (4,353) | (4,353) | ||
Net Change in Fair Value on Equity Investments at FVTOCI | - | - | 128 | - | 128 | ||
Total Comprehensive Income for the Year | - | 203,481 | 128 | 472,855 | 676,464 | ||
Transactions with Owners in their capacity as Owners | |||||||
Dividend Paid - Ordinary Shares | - | - | - | (74,520) | (74,520) | ||
- | - | - | (74,520) | (74,520) | |||
Balance as at 31st March 2021 | 916,366 | 2,134,544 | 128 | 1,986,400 | 5,037,438 | ||
Net Profit for the six months ended 30 September 2021 | - | - | - | 423,386 | 423,386 | ||
Other Comprehensive Income | |||||||
Net Change in Fair Value on Equity Investments at FVTOCI | - | - | 64 | - | 64 | ||
Total Comprehensive Income for the Six months ended 30 September 2021 | - | - | 64 | 423,386 | 423,450 | ||
Transactions with Owners in their capacity as Owners | |||||||
Dividend Paid - Ordinary Shares | - | - | - | (108,393) | (108,393) | ||
- | - | - | (108,393) | (108,393) | |||
Balance as at 30th September 2021 | 916,366 | 2,134,544 | 192 | 2,301,393 | 5,352,495 |
Ceylon Hospitals PLC | - 4 - |
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Ceylon Hospitals plc published this content on 14 November 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 14 November 2022 03:31:03 UTC.